Journal of Clinical Oncology· Sam O. Kleeman·收录于· 10 小时前AI 评分55
HER2 阳性早期乳腺癌新辅助治疗的风险适应性优化
Risk-Adapted Optimization of Neoadjuvant Therapy in Human Epidermal Growth Factor Receptor 2–Positive Early-Stage Breast Cancer
AI 导读
Journal of Clinical Oncology 在线发表一篇题为《Risk-Adapted Optimization of Neoadjuvant Therapy in Human Epidermal Growth Factor Receptor 2–Positive Early-Stage Breast Cancer》的文章。
来源：Journal of Clinical Oncology · ascopubs.org